Toll样受体2在泛癌中的表达、对预后的影响及其作用机制
陈胜武, 赵恒伍, 高轶轩锦州医科大学附属第三医院骨科, 辽宁 锦州 121001
收稿日期:
2022-06-06出版日期:
2022-09-30发布日期:
2022-09-03通讯作者:
赵恒伍E-mail:8248785@qq.com作者简介:
陈胜武(1982-),男,副主任医师,博士.基金资助:
辽宁省教育厅科学研究经费项目(LJKZ0798)关键词: Toll样受体2, 泛癌, 免疫浸润, 基因变异, 预后
Abstract: Objective To analyze the expression of Toll-like receptor 2(TLR2) in pan cancer, its effects on prognosis, and underlying mechanisms. Methods UCSC Xena database was used to analyze the differential expression of TLR2 in tumor tissue and normal tissues. The effect of TLR2 on prognosis in pan cancer was analyzed using the R language. Mutations of TLR2 gene were analyzed in the cBioPortal database. The correlation between TLR2 expression and tumor immune infiltrating cells was analyzed with the TIMER database. The biological function of TLR2 was analyzed using the Gene Set Enrichment Analyses(GSEA) software. Results There was a significant difference in TLR2 expression between pan cancerous tissues and adjacent normal tissues. The differential expression of TLR2 was related to the poor prognosis of many types of tumors, in which gene mutation plays an important role. TLR2 had a strong correlation with immune cell infiltration and immune regulators in tumor tissues. GSEA showed that TLR2 was associated with tumor immune and inflammatory pathways. Conclusion Comprehensive pan cancer analysis confirmed that TLR2 is a biomarker for immune infiltration and poor cancer prognosis. TLR2 could be a new target for immune regulation, which can be used to develop new targeted immunotherapy drugs and provide new insights into tumor treatment.
Key words: Toll-like receptor 2, pan cancer, immune infiltration, gene variation, prognosis
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=3068